BTRX-335140(CYM-53093 structure
|
Common Name | BTRX-335140(CYM-53093 | ||
|---|---|---|---|---|
| CAS Number | 2244614-14-8 | Molecular Weight | 453.55 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H32FN5O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BTRX-335140(CYM-53093BTRX-335140 (CYM-53093) is a potent and selective, orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively.BTRX-335140 endows with favorable in vitro ADMET and in vivo pharmacokinetic profiles and medication-like duration of action in rats. BTRX-335140 can distribute well into the CNS. ADMET (absorption, distribution, metabolism, excretion, and toxicity) [1]. |
| Name | BTRX-335140 |
|---|
| Description | BTRX-335140 (CYM-53093) is a potent and selective, orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively.BTRX-335140 endows with favorable in vitro ADMET and in vivo pharmacokinetic profiles and medication-like duration of action in rats. BTRX-335140 can distribute well into the CNS. ADMET (absorption, distribution, metabolism, excretion, and toxicity) [1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.8 nM (κOR); 110 nM (μOR); 6500 nM (δOR)[1] |
| References |
| Molecular Formula | C25H32FN5O2 |
|---|---|
| Molecular Weight | 453.55 |
| InChIKey | CQOJHAJWCDJEAT-UHFFFAOYSA-N |
| SMILES | CCc1cc(F)c2nc(N3CCC(NC4CCOCC4)CC3)c(-c3nc(C)no3)c(C)c2c1 |
| Storage condition | 2-8°C |